Want to see IN:NATHBIOGEN full AI Analyst Report?

Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Price & Analysis

3 Followers

NATHBIOGEN Stock Chart & Stats

₹158.80

-₹4.15(-2.25%)

At close: Jan 08 4:00 PM EST

₹158.80

-₹4.15(-2.25%)

Day’s Range― - ―

52-Week Range₹126.75 - ₹238.00

Previous CloseN/A

Volume20.69K

Average Volume (3M)2.58K

Market Cap

₹3.19B

Enterprise Value₹3.80B

Total Cash (Recent Filing)₹1.59B

Total Debt (Recent Filing)₹1.55B

Price to Earnings (P/E)8.3

Beta1.17

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.26%

Share Statistics

EPS (TTM)21.68

Shares Outstanding19,004,000

10 Day Avg. Volume2,256

30 Day Avg. Volume2,581

Financial Highlights & Ratios

PEG Ratio1.86

Price to Book (P/B)0.38

Price to Sales (P/S)0.58

P/FCF Ratio-10.22

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetThe company's low debt-to-equity (~0.16–0.19) and steadily building equity indicate durable financial flexibility. Low leverage supports capital allocation for R&D, seasonal working capital, and weathering poor harvest cycles without forcing dilutive financing, preserving long-term strategic optionality.

Sustained ProfitabilityConsistent positive net and double-digit operating margins reflect underlying product pricing power and cost discipline in seed production. Sustained profitability supports reinvestment in breeding programs, margin resilience across cycles, and the ability to fund distribution and channel development over multiple seasons.

Improving Revenue TrendA rebound in revenue growth suggests improving product adoption or market share recovery. For a seed company, accelerating top-line supports scale in production, better utilization of processing assets, and stronger bargaining with distributors, which can sustainably lift earnings over ensuing planting seasons.

Bears Say

Weak Cash GenerationNegative operating and free cash flow despite accounting profits signals weak cash conversion, likely from working-capital swings or timing of collections/payments. This reduces near-term self-funding for seed production cycles, increases reliance on external financing, and raises execution risk across seasons.

Margin CompressionA material fall in net margins from ~16% to ~9% indicates pricing pressure, rising input or processing costs, or unfavorable product mix shifts. Sustained compression undermines free cash generation and limits scope for reinvestment in breeding and distribution, weakening long-term competitive positioning.

Earnings Volatility / Historical LossA prior sharp loss and only moderate ROE (~6%) show earnings volatility tied to crop cycles, R&D outcomes, or execution. Structural volatility makes forecasting adoption of new hybrids harder and increases the risk premium for longer-term commitments from dealers and investors, constraining growth plans.

Nath Bio-Genes (India) Ltd. News

Nath Bio-Genes Releases Investor Presentation on Unaudited Q3 and 9MFY26 Results

Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) has issued an announcement. Nath Bio-Genes (India) Ltd. has released an...

5M ago

Nath Bio-Genes Shuts Trading Window Ahead of Q3 FY26 Results

Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) has provided an update. Nath Bio-Genes (India) Ltd. has announced that...

6M ago

Nath Bio-Genes Ensures Regulatory Compliance with SEBI Regulations

An update from Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) is now available. Nath Bio-Genes (India) Ltd. has...

9M ago

Nath Bio-Genes Releases Q3 FY25 Financial Results

An update from Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) is now available. Nath Bio-Genes (India) Limited has...

1y ago

NATHBIOGEN FAQ

What was Nath Bio-Genes (India) Ltd.’s price range in the past 12 months?

Nath Bio-Genes (India) Ltd. lowest stock price was ₹126.75 and its highest was ₹238.00 in the past 12 months.

What is Nath Bio-Genes (India) Ltd.’s market cap?

Nath Bio-Genes (India) Ltd.’s market cap is ₹3.19B.

When is Nath Bio-Genes (India) Ltd.’s upcoming earnings report date?

Nath Bio-Genes (India) Ltd.’s upcoming earnings report date is Aug 06, 2026 which is in 32 days.

How were Nath Bio-Genes (India) Ltd.’s earnings last quarter?

Nath Bio-Genes (India) Ltd. released its earnings results on May 04, 2026. The company reported -₹0.79 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.79.

Is Nath Bio-Genes (India) Ltd. overvalued?

According to Wall Street analysts Nath Bio-Genes (India) Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Nath Bio-Genes (India) Ltd. pay dividends?

Nath Bio-Genes (India) Ltd. pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 1.26%. See more information on Nath Bio-Genes (India) Ltd. dividends here

What is Nath Bio-Genes (India) Ltd.’s EPS estimate?

Nath Bio-Genes (India) Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nath Bio-Genes (India) Ltd. have?

Nath Bio-Genes (India) Ltd. has 19,004,000 shares outstanding.

What happened to Nath Bio-Genes (India) Ltd.’s price movement after its last earnings report?

Nath Bio-Genes (India) Ltd. reported an EPS of -₹0.79 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.393%.

Which hedge fund is a major shareholder of Nath Bio-Genes (India) Ltd.?

Currently, no hedge funds are holding shares in IN:NATHBIOGEN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Nath Bio-Genes (India) Ltd.

Nath Bio-Genes (India) Limited is dedicated to the development, preparation, and worldwide distribution of both hybrid and genetically modified (GM) seeds, catering to demand within India and internationally. Its business operations are organized into two main divisions: agricultural pursuits and trading endeavors. The company provides a wide array of seeds, including: Cereals: Maize, paddy, millet, wheat, and jowar. Fruits: Various fruit seed varieties. Fiber and Oil-Producing Crops: Notably cotton and mustard. Vegetables: A comprehensive selection such as chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. Additionally, Nath Bio-Genes supplies agricultural enhancement products, offering crop protection supplements like the WINPro GOLii, WINall, and Win Chi Win growth enhancers. It also provides forage supplements, NUTRIMAX GOLD and NUTRIMAX, specifically formulated to boost fodder production. The company disseminates its products via an extensive network that includes distributors, dealers, and its own processing facilities. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.